CD8-CELLS RESPONDING TO RESIDUAL CLASS-I ANTIGENS, WITH HELP FROM CD4(+) CELLS STIMULATED INDIRECTLY, CAUSE REJECTION OF MAJOR HISTOCOMPATIBILITY COMPLEX-DEFICIENT SKIN-GRAFTS( EFFECTOR)
Rs. Lee et al., CD8-CELLS RESPONDING TO RESIDUAL CLASS-I ANTIGENS, WITH HELP FROM CD4(+) CELLS STIMULATED INDIRECTLY, CAUSE REJECTION OF MAJOR HISTOCOMPATIBILITY COMPLEX-DEFICIENT SKIN-GRAFTS( EFFECTOR), Transplantation, 63(8), 1997, pp. 1123-1133
Background. Skin grafts from mice that are deficient in the expression
of both class I and class II major histocompatibility complex (MHC) a
ntigens are rejected rapidly by normal recipients. Methods. To determi
ne the mechanism of this rejection, MHC-deficient skin grafts were pla
ced on recipients with different degrees of antigenic disparity and on
recipients depleted of selected T cell subpopulations, In addition, t
he recipient's T cells were examined in vitro for their responses befo
re and after graft rejection. Results. The results indicate that (1) C
D4(+) cells provide help for this rejection by recognizing donor antig
ens presented by recipient class II antigens, and (2) CD8(+) cells can
participate as effector cells, recognizing residual class I antigens
expressed by the MHC-deficient grafts. Conclusions. The primary conclu
sion from these studies is that the supposedly MHC-deficient mice actu
ally do have sufficient class I antigen expression to cause skin graft
rejection, This finding prevents the use of these mice to answer defi
nitively the question of whether grafts entirely lacking MHC antigens
would be rejected, However, these studies do illustrate two important
(although previously recognized) features of allogeneic skin graft rej
ection: (1) that rejection can be initiated by help provided entirely
through the indirect pathway, and (2) that help provided through the i
ndirect pathway is available for effector T cells sensitized directly
by donor cells, However, the results from these and other studies sugg
est that indirect effector mechanisms would probably be able to destro
y truly MHC-deficient grafts under some circumstances.